Hepatocellular Carcinoma

Other names: HCC; Liver Cancer; Malignant Hepatoma

Hepatocellular Carcinoma is malignant tumor of the liver that develops in the setting of chronic liver disease or cirrhosis.

Name	Drug Class	Updated
Cabozantinib	Multikinase inhibitors	15-Aug-2023
Sorafenib	Multikinase inhibitors	15-Aug-2023
Atezolizumab	Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)	13-Aug-2023
Tremelimumab (monograph)	Drugs	12-Aug-2023
Regorafenib	Multikinase inhibitors	12-Aug-2023
Ramucirumab	VEGF/VEGFR inhibitors	12-Aug-2023
Nivolumab	Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)	11-Aug-2023
Lenvatinib	Multikinase inhibitors	11-Aug-2023
Stivarga	Multikinase inhibitors	14-Jul-2023
Nexavar	Multikinase inhibitors	13-Jul-2023
Imjudo	Anti-CTLA-4 monoclonal antibodies	13-Jul-2023
Cyramza	VEGF/VEGFR inhibitors	13-Jul-2023
Tecentriq	Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)	12-Jul-2023
Opdivo	Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)	11-Jul-2023
Lenvima	Multikinase inhibitors	11-Jul-2023
Cabometyx	Multikinase inhibitors	10-Jul-2023

TheMediTary.Com